[HTML][HTML] Genetic screening for the risk of type 2 diabetes: worthless or valuable?

V Lyssenko, M Laakso - Diabetes care, 2013 - ncbi.nlm.nih.gov
The prevalence and incidence of type 2 diabetes, representing. 90% of all cases of diabetes,
are increasing rapidly throughout the world. The International Diabetes Federation has …

[HTML][HTML] Mindfulness-based programs in the workplace: a meta-analysis of randomized controlled trials

R Vonderlin, M Biermann, M Bohus, L Lyssenko - Mindfulness, 2020 - Springer
Objectives Given the complex demands of many workplaces, there is growing interest in the
potential beneficial effects of mindfulness-based programs (MBPs) for employees. This meta-…

[HTML][HTML] Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene

H Mulder, CLF Nagorny, V Lyssenko, L Groop - Diabetologia, 2009 - Springer
Melatonin is a circulating hormone that is primarily released from the pineal gland. It is best
known as a regulator of seasonal and circadian rhythms; its levels are high during the night …

Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels

R Saxena, BF Voight, V Lyssenko, NP Burtt… - Science, 2007 - science.org
New strategies for prevention and treatment of type 2 diabetes (T2D) require improved insight
into disease etiology. We analyzed 386,731 common single-nucleotide polymorphisms (…

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

…, O Le Bacquer, C Lecoeur, Y Li, V Lyssenko… - Nature …, 2010 - nature.com
Levels of circulating glucose are tightly regulated. To identify new loci influencing glycemic
traits, we performed meta-analyses of 21 genome-wide association studies informative for …

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes

…, H Lango, T Lauritzen, Y Li, CM Lindgren, V Lyssenko… - Nature …, 2008 - nature.com
Genome-wide association (GWA) studies have identified multiple loci at which common variants
modestly but reproducibly influence risk of type 2 diabetes (T2D) 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , …

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis

…, M Li, A Lieverse, CM Lindgren, V Lyssenko… - Nature …, 2010 - nature.com
By combining genome-wide association data from 8,130 individuals with type 2 diabetes (T2D)
and 38,987 controls of European descent and following up previously unidentified meta-…

[HTML][HTML] Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes

V Lyssenko, R Lupi, P Marchetti… - The Journal of …, 2007 - Am Soc Clin Investig
Transcription factor-7–like 2 (TCF7L2) is the most important type 2 diabetes susceptibility
gene identified to date, with common intronic variants strongly associated with diabetes in all …

Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps

…, S Ligthart, CM Lindgren, A Linneberg, V Lyssenko… - Nature …, 2018 - nature.com
We expanded GWAS discovery for type 2 diabetes (T2D) by combining data from 898,130
European-descent individuals (9% cases), after imputation to high-density reference panels. …

[HTML][HTML] Clinical risk factors, DNA variants, and the development of type 2 diabetes

V Lyssenko, A Jonsson, P Almgren… - … England Journal of …, 2008 - Mass Medical Soc
Background Type 2 diabetes mellitus is thought to develop from an interaction between
environmental and genetic factors. We examined whether clinical or genetic factors or both could …